Mehabe score: 2 G Factor: 5 Piotski Score: 6 The stock has a rating HOLD. The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 5 and Piotski score of 6.
Description
Kriti Nutrients is in the business of Soya Seed Extraction and Manufacturing & Selling of cooking oil under its own brand KRITI.Site:533210Main Symbol:KRITINUT
Stock trades at 44.2, below its 50dma 44.63. However it is trading above its 200dma 40.89. The stock remains weak in the short term due to near term bearish momentum. However overall bullish structure remains intact. Price action will further build up as it moves above its dma50, currently situated at 44.63.
The 52 week high is at 53.30 and the 52week low is at 29.45
Price Chart
P/E Chart
Sales and Margin
Strengths
– has reduced debt.
– is almost debt free.
– is expected to give good quarter
Weakness
–
Competition
– The industry trades at a mean P/E of 31.9x. Manorama Indust. trades at the industry’s max P/E of 94.24x. 533210 trades at a P/E of 25.0x
– Industry’s mean G-Factor is 4.4 while the mean Piotski score is 7.0. 533210 has a G-Factor of 5 and Piotski scoreof 6.
– Average 1 month return for industry is 4.3%. The max 1- month return was given by Vijay Solvex: a return of 60.23 %
Quarterly Results
Sales for period ended Jun 2021 is Rs 159.7 cr compared to Rs 170.44 cr for period ended Jun 2020, a fall of 6.3%
Operating Profits reported at Rs 2.63 cr for period ended Jun 2021 vis-vis 11.17 for period ended Jun 2020 .
Operating Margins contracted -490.7 bps for period ended Jun 2021 vis-vis Jun 2020 .
The EPS for Jun 2021 was Rs 0.39 compared to Rs 0.3 for previous quarter ended Mar 2021 and Rs 1.63 for Jun 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 679.0 cr for period ended TTM vis-vis sales of Rs 690.0 cr for the period ended Mar 2021, a fall of 1.6%. The 3 year sales cagr stood at 11.9%.
Operating margins shrank to 2.0% for period ended TTM vis-vis 3.0% for period ended Mar 2021, contraction of 100.0 bps.
Net Profit reported at Rs 9.0 cr for period ended TTM vis-vis sales of Rs 15.0 cr for the period ended Mar 2021, falling 66.7%.
Company reported a poor Net Profit CAGR of -19.1% over the last 3 years
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
CashFlow from operating activities was positive.
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The company has worsened on its Return on Equity (RoE) metric. The RoE on Last Year basis was 16.0% compared to 22.0% over the last 3 Years. – The stock has given a return of 1% on a 1 Year basis vis-vis a return of 5% over the last 3 Years. – The compounded sales growth on a TTM bassis is 24% vis-vis a compounded sales growth of 14% over the last 3 Years. – The compounded profit growth on a TTM basis is -62% vis-vis a compounded profit growth of -2% over the last 3 Years.
Ratios
Shareholding Pattern
– FII shareholding has remained largely constant. The Jun 2021 fii holding stood at 0.0% vis-vis 0.0% for Mar 2021 – Public shareholding has remained largely constant. The Jun 2021 public holding stood at 33.65% vis-vis 33.65% for Mar 2021
Conclusion
– has reduced debt.
– is almost debt free.
– is expected to give good quarter –
The business fundamentals of the stock remain stable. Stronger near term results will build interest in the stock. We suggest to wait for a upturn in business performance.
Technically, the stock remains below its 50 DMA 44.63 and is trading at 44.2. Shows a near term lack of buying interest.
